Phenomix expands evidence for GLP-1 response predicting MyPhenome test New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.

Phenomix Sciences unveils new data at #ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity

Phenomix expands evidence for GLP-1 response predicting MyPhenome test New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.

Phenomix Sciences unveils new data at #ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity

Phenomix Sciences Advances MyPhenome™ Test for Predicting Obesity and GLP-1 Response in Diverse Populations Phenomix Sciences showcases its MyPhenome test at Obesity Week 2025, revealing its effectiveness in predicting responses to GLP-1 treatments across varied populations.

Phenomix Sciences Advances MyPhenome™ Test for Predicting Obesity and GLP-1 Response in Diverse Populations #United_States #Menlo_Park #GLP-1 #Phenomix #MyPhenome

Phenomix and Mayo Clinic Publish Groundbreaking Study on MyPhenome Test for Personalized Obesity Treatment Phenomix Sciences and Mayo Clinic have published a significant study validating the MyPhenome genetic test, enhancing the personalization of obesity treatments based on individual biology.

Phenomix and Mayo Clinic Publish Groundbreaking Study on MyPhenome Test for Personalized Obesity Treatment #USA #Menlo_Park #Mayo_Clinic #Phenomix #MyPhenome